RUJA: Repositorio Institucional de Producción Científica

 

Significance of PD1 Alternative Splicing in Celiac Disease as a Novel Source for Diagnostic and Therapeutic Target

dc.contributor.authorPonce-de-León, Candelaria
dc.contributor.authorLorite, Pedro
dc.contributor.authorLópez-Casado, Miguel Ángel
dc.contributor.authorBarro, Francisco
dc.contributor.authorPalomeque, Teresa
dc.contributor.authorTorres-López, María Isabel
dc.date.accessioned2025-01-17T09:28:44Z
dc.date.available2025-01-17T09:28:44Z
dc.date.issued2021-06
dc.descriptionEn pro de mi compromiso con la difusión de la ciencia, este artículo se encuentra depositado, siguiendo las normas establecidas por la editorial de la revista, en el repositorio de la Universidad de Jaén (RUJA) con su identificador persistente. Debe vincularse al artículo publicado https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2021.678400/fulles_ES
dc.description.abstractThis study examines the role of the PD-1/PD-L1 pathway in celiac disease (CD), focusing on its involvement in immune regulation and the impact of altered mRNA splicing on identifying new diagnostic, prognostic, and therapeutic targets. The findings revealed an overexpression of the sPD-1 protein and the PD-1Dex3 transcript in CD. Three novel spliced isoforms were identified: two producing truncated proteins and one encoding a soluble PD-1 variant (sPD-1) due to a loss of exon 3 and part of exon 2. These results suggest that dietary gluten influences cell homeostasis by modulating pre-mRNA splicing of key regulatory proteins, serving as an adaptive response to dietary changes.es_ES
dc.identifier.citationPonce de León C, Lorite P, López-Casado MÁ, Barro F, Palomeque T, Torres MI. Significance of PD1 Alternative Splicing in Celiac Disease as a Novel Source for Diagnostic and Therapeutic Target. Front Immunol. 2021;12:678400.es_ES
dc.identifier.issn1664-3224es_ES
dc.identifier.other10.3389/fimmu.2021.678400es_ES
dc.identifier.urihttps://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2021.678400/fulles_ES
dc.identifier.urihttps://hdl.handle.net/10953/4029
dc.language.isoenges_ES
dc.relation.ispartofFrontiers in Immunologyes_ES
dc.rightsAtribución-NoComercial-SinDerivadas 3.0 España*
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses_ES
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/es/*
dc.subjectPD1/PDL1es_ES
dc.subjectCeliac diseasees_ES
dc.subjectAlternative splicinges_ES
dc.subjectGluten peptideses_ES
dc.subjectImmune checkpointes_ES
dc.subject.udc6 Ciencias aplicadas. Medicina. Tecnología.es_ES
dc.titleSignificance of PD1 Alternative Splicing in Celiac Disease as a Novel Source for Diagnostic and Therapeutic Targetes_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.type.versioninfo:eu-repo/semantics/acceptedVersiones_ES

Archivos

Bloque original

Mostrando 1 - 1 de 1
Cargando...
Miniatura
Nombre:
fimmu-12-678400 (2).pdf
Tamaño:
11.86 MB
Formato:
Adobe Portable Document Format
Descripción:

Bloque de licencias

Mostrando 1 - 1 de 1
No hay miniatura disponible
Nombre:
license.txt
Tamaño:
1.98 KB
Formato:
Item-specific license agreed upon to submission
Descripción:

Colecciones